ATSP7041 is a hydrocarbon-stapled α-helical peptide engineered to inhibit specific protein-protein interactions. The stapling constraint stabilizes helix content and enhances proteolytic resistance. Researchers study its binding thermodynamics, cell permeability, and structural features by biophysical methods. Applications include PPI-modulation research, stapled-peptide technology development, and conformational-constraint studies.
ATSP7041 is a synthetic peptide-based small molecule inhibitor designed to disrupt protein-protein interactions involving the p53 tumor suppressor pathway, most notably by targeting the MDM2 and MDMX (also known as MDM4) oncoproteins. As a stabilized alpha-helical peptide mimetic, ATSP7041 exhibits enhanced binding affinity and proteolytic stability, making it a valuable tool for probing the molecular mechanisms that regulate p53 activity. Its biochemical significance lies in its ability to mimic the transactivation domain of p53, thereby competitively inhibiting the interaction between p53 and its negative regulators. This property has positioned ATSP7041 as an important research reagent for studies focused on cellular stress responses, apoptosis, and the broader landscape of protein-protein interaction modulation.
Protein-Protein Interaction Research: ATSP7041 is widely utilized in studies investigating the structural and functional dynamics of protein-protein interactions, particularly those involving the p53-MDM2/MDMX axis. By serving as a high-affinity antagonist, it enables researchers to dissect the molecular determinants of binding specificity, conformational changes, and interaction kinetics. This facilitates the elucidation of key regulatory checkpoints within signaling pathways where p53 plays a central role, aiding in the identification of novel regulatory motifs and potential intervention points for future research.
Cellular Pathway Analysis: In cell-based assays, the compound provides a robust means to modulate the functional status of p53 by preventing its ubiquitination and subsequent proteasomal degradation. This stabilization of p53 leads to altered transcriptional profiles and downstream effects on cell cycle regulation, DNA damage responses, and programmed cell death. As a result, ATSP7041 is instrumental in experimental systems designed to map the cellular consequences of p53 reactivation, allowing for detailed analysis of gene expression changes and phenotypic outcomes following pathway perturbation.
Peptide-Targeted Screening Assays: The unique structural features of ATSP7041 make it a preferred reference compound in high-throughput screening platforms aimed at identifying novel modulators of the p53-MDM2/MDMX interaction. Its well-characterized binding profile provides a benchmark for evaluating the efficacy and specificity of new peptide-based or small molecule inhibitors. This application is particularly valuable in the context of structure-activity relationship (SAR) studies, where it serves as a positive control to validate assay performance and guide the optimization of next-generation inhibitors.
Biophysical and Structural Biology Studies: The stabilized alpha-helical conformation of this peptide mimetic is exceptionally suited for use in biophysical techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and surface plasmon resonance (SPR). These approaches leverage the compound's high affinity and defined structure to resolve interaction interfaces, binding energetics, and conformational dynamics at atomic or near-atomic resolution. Such studies provide critical insights into the molecular basis of p53 regulation and inform the rational design of improved peptide mimetics.
Chemical Biology Tool Development: Beyond its direct inhibitory activity, ATSP7041 serves as a versatile scaffold for the development of new research tools in chemical biology. Its modular peptide backbone and amenability to chemical modification enable the generation of fluorescently labeled derivatives, affinity probes, or conjugates for target validation studies. These functionalized analogs expand the experimental repertoire for investigating protein interaction networks, facilitating the exploration of intracellular localization, target engagement, and downstream signaling events in live-cell or in vitro systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More